Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers

NCT01984983 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Venezuelan Equine Encephalitis Virus Infection

Interventions

BIOLOGICAL: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate
OTHER: 0.9% saline placebo

Sponsor

Ichor Medical Systems Incorporated

Collaborators

[object Object]